Ivel De Freitas is a medical doctor and researcher and author in the fields of longevity, immunology and epigenetics.

She is the founder of ONOGEN, an organization dedicated to creating a new foundation for reengineering healthcare in the AI era.

Dr. De Freitas is a pioneer in the development of personalized biomolecular medicine, incorporating concepts such as biomolecular enhancement to regenerative medicine.

Graduated top of her class, with a sophisticated educational and professional background which includes: Internal Medicine at Yale University; Mind Body Medicine at Harvard Medical School (Benson-Henry Institute); Fellowship in Anti-Aging, Functional and Regenerative Medicine at American Academy of Anti-Aging Medicine and Integrative Nutrition at the Institute for Integrative Nutrition, State University of New York (SUNY).

Dr. De Freitas’ multidisciplinary background allows her to apply the latest research and technology in genetics, immunology and neurobehavioral science with a holistic approach, responsibly translating cutting edge research into her medical practice.
Her positive energy, empathy, love, and forward-thinking passion for medicine and technology drives her to promote a medical reform movement. A medical revolution that champions patient preference, supporting the shift of our current outdated medical model towards a more participative, equalitarian and inclusive healthcare system.